King Pharmaceuticals KG International — Year 10
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearTen.
The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's international — year 10.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's international — year 10?
- King Pharmaceuticals (KG) reported international — year 10 of -0.8% in Q4 2025.
- What does international — year 10 mean?
- Captures the financial performance and operational results of the International insurance product line during the tenth year of the reporting cycle. This metric serves as a key indicator of the segment's decade-long performance, profitability, and market influence. It is critical for assessing the long-term value creation of the international insurance business.